Cargando…

Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer

BACKGROUND: Loss of activity of tumor suppressor genes is considered a fundamental step in a genetic model of carcinogenesis. Altered expression of the p53 and the Deleted in Colon Cancer (DCC) proteins has been described in gastric cancer and this event may have a role in the development of the dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graziano, Francesco, Cascinu, Stefano, Staccioli, Maria Pia, Catalano, Vincenzo, Rossi, Maria Cristina, Baldelli, Anna Maria, Giordani, Paolo, Muretto, Pietro, Catalano, Giuseppina
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC37544/ https://www.ncbi.nlm.nih.gov/pubmed/11518545 http://dx.doi.org/10.1186/1471-2407-1-9

Ejemplares similares

An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation
por: Cascinu, S, et al.
Publicado: (2002)

Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas.
por: Patterson, H., et al.
Publicado: (1994)

A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer
por: Cascinu, S, et al.
Publicado: (2001)

Defining the Ligand Specificity of the Deleted in Colorectal Cancer (DCC) Receptor
por: Haddick, Patrick C. G., et al.
Publicado: (2014)

Early and Complete Response of Bone Metastases, Documented by FDG-PET/CT Scan, in a Patient With NSCLC
por: Rossi, David, et al.
Publicado: (2012)

Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers.
por: Goi, T., et al.
Publicado: (1998)

Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
por: Catalano, V, et al.
Publicado: (2008)

Selective depletion of tumour suppressors Deleted in Colorectal Cancer (DCC) and neogenin by environmental and endogenous serine proteases: linking diet and cancer
por: Forrest, Caroline M., et al.
Publicado: (2016)

Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer : A low cost effective regimen
por: Cascinu, S, et al.
Publicado: (2002)

Over-D1 dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients
por: Scartozzi, M, et al.
Publicado: (2005)

Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial
por: Santini, D, et al.
Publicado: (2006)

“Short Course” of Nonpegylated Liposomal Doxorubicin Plus Paclitaxel and Trastuzumb as Primary Systemic Therapy for Operable and Locally-Advanced Breast Cancer: A Phase II Study (PacLiDox 07)
por: Rossi, D., et al.
Publicado: (2011)

The Prognostic Value of Deleted in Colorectal Cancer (DCC) Receptor and Serum Netrin-1 in Severe Traumatic Brain Injury
por: Zhang, Yuanda, et al.
Publicado: (2022)

A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy.
por: Cascinu, S., et al.
Publicado: (1995)

Cisplatin, 5-fluorouracil and interferon alpha 2b for recurrent or metastatic head and neck cancer.
por: Cascinu, S., et al.
Publicado: (1994)

Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
por: Cascinu, S., et al.
Publicado: (1998)

Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients
por: Scartozzi, M, et al.
Publicado: (2006)

Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2015)

Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer.
por: Thompson, A. M., et al.
Publicado: (1993)

Anti-NMDA Receptor Encephalitis in a Patient with Previous Psychosis and Neurological Abnormalities: A Diagnostic Challenge
por: Heekin, R. David, et al.
Publicado: (2015)

Present Status and Future of DCC Analysis
por: Nayak, Tapank K., et al.
Publicado: (1998)

Ontology application and use at the ENCODE DCC
por: Malladi, Venkat S., et al.
Publicado: (2015)

Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients
por: Graziano, F, et al.
Publicado: (2002)

Chronology of gastrointestinal cancer
por: Murakami, Kentaro, et al.
Publicado: (2017)

Chronology of Thyroid Cancer
por: Miyauchi, Akira
Publicado: (2022)

A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer
por: Graziano, F, et al.
Publicado: (2003)

Suppressed tumorigenicity of human endometrial cancer cells by the restored expression of the DCC gene
por: Kato, H, et al.
Publicado: (2000)

Neogenin May Functionally Substitute for Dcc in Chicken
por: Phan, Keith Dai, et al.
Publicado: (2011)

Evolution of the functionally conserved DCC gene in birds
por: Patthey, Cedric, et al.
Publicado: (2017)

Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study.
por: Cascinu, S., et al.
Publicado: (1993)

Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy
por: Catalano, V, et al.
Publicado: (2009)

The binding of DCC-P3 motif and FAK-FAT domain mediates the initial step of netrin-1/DCC signaling for axon attraction
por: Xu, Shutong, et al.
Publicado: (2018)

Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer
por: Sato, K, et al.
Publicado: (2001)

Dcc Regulates Asymmetric Outgrowth of Forebrain Neurons in Zebrafish
por: Gao, Jingxia, et al.
Publicado: (2012)

Dcc Mediates Functional Assembly of Peripheral Auditory Circuits
por: Kim, Young J., et al.
Publicado: (2016)

Recurrent DCC gene losses during bird evolution
por: Friocourt, François, et al.
Publicado: (2017)

Heterozygous variants in DCC: Beyond congenital mirror movements
por: Thams, Sebastian, et al.
Publicado: (2020)

A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
por: Cascinu, S, et al.
Publicado: (1999)

Frequent reduction or loss of DCC gene expression in human osteosarcoma.
por: Horstmann, M. A., et al.
Publicado: (1997)

Neural function in DCC mutation carriers with and without mirror movements
por: Vosberg, Daniel E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p008ubin0glbe994nfcqhddbcg